PTHS PTHS Transfer of liabilities to Chromocell Corporation for Series C Preferred Stock
Transfer of liabilities to Chromocell Corporation for Series C Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by PTHS in its filing.
Tagged under the XBRL concept pths:TransferOfLiabilitiesToCounterpartyForCommonStock.
The official record: PTHS’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTHS's transfer of liabilities to chromocell corporation for series c preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTHS's transfer of liabilities to chromocell corporation for series c preferred stock?
- PTHS (PTHS) reported transfer of liabilities to chromocell corporation for series c preferred stock of $0 in Q4 2025.
- How has PTHS's transfer of liabilities to chromocell corporation for series c preferred stock changed year-over-year?
- PTHS's transfer of liabilities to chromocell corporation for series c preferred stock decreased by 100.0% year-over-year, from $538.25K to $0.
- What does transfer of liabilities to chromocell corporation for series c preferred stock mean?
- This metric represents the non-cash settlement of corporate obligations through the issuance of equity instruments to a counterparty. It reflects a strategic capital restructuring effort to reduce debt burdens or settle liabilities without utilizing cash reserves. Investors monitor this to assess the impact of equity dilution on existing shareholders relative to the reduction in financial leverage.